Subscribe

Stay Informed. Stay Ahead.

Subscribe to receive curated updates, expert insights, and practical education—delivered straight to your inbox.

Get timely coverage on new approvals, case-based discussions, conference highlights, and practical tools for everyday practice in community oncology and hematology.

Subscribe
*
Skip to main content
OncUpdates
  • Conferences
    • ASCO
      • Rapid Reactions
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
  • Videos & Podcasts
    • Challenging Cases
      • Breast Cancer
      • GU Oncology
      • Hematology
      • Lung Cancer
    • New Approvals
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Tox Check
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • GI Oncology
      • GU Oncology
      • Head and Neck Cancers
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • Head & Neck Cancer
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastric/GEJ Cancer
      • Pancreatic Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
      • Multiple Myeloma
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Cell Therapy
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • GU Oncology
    • Hematology
    • Lung Cancer
  • Events
  • Conferences
    • ASCO
      • Rapid Reactions
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
  • Videos & Podcasts
    • Challenging Cases
      • Breast Cancer
      • GU Oncology
      • Hematology
      • Lung Cancer
    • New Approvals
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Tox Check
      • Breast Cancer
      • GI Oncology
      • GU Oncology
      • Hematology
      • Lung Cancer
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • GI Oncology
      • GU Oncology
      • Head and Neck Cancers
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
  • Clinical Insights
    • Head & Neck Cancer
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastric/GEJ Cancer
      • Pancreatic Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
      • Multiple Myeloma
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Cell Therapy
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • GU Oncology
    • Hematology
    • Lung Cancer
  • Events

Explore Videos, Articles & More

Polycythemia Vera

Expert-led insights on the management of polycythemia vera, including hematocrit control strategies, symptom burden, and evolving therapeutic approaches. Highlights emerging data and treatment considerations to support individualized, evidence-based care.

Home / Clinical Insights / Hematology / Polycythemia Vera

PV AT ASCO 2026

Browse all PV AT ASCO 2026
Clinical Insights: Role of Ropeginterferon Alfa-2b-njft in Polycythemia Vera

PV AT ASCO 2026

Clinical Insights: Role of Ropeginterferon Alfa-2b-njft in Polycythemia Vera

Aaron Gerds, MD, Anthony M. Hunter, MD, Anand Patel, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

PV AT ASH 2025

Browse all PV AT ASH 2025
Ep. 4: Managing Fatigue and Phlebotomy Burden in PV With Rusfertide

PV AT ASH 2025

Ep. 4: Managing Fatigue and Phlebotomy Burden in PV With Rusfertide

Talha Badar, MBBS, MD, Aaron Gerds, MD, Andrew Kuykendall, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Ep. 3: Managing Hematocrit and Symptoms in PV: Dose-Titration Strategies for Rusfertide

PV AT ASH 2025

Ep. 3: Managing Hematocrit and Symptoms in PV: Dose-Titration Strategies for Rusfertide

Talha Badar, MBBS, MD, Aaron Gerds, MD, Andrew Kuykendall, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Ep. 2: Integrating Rusfertide Into the Polycythemia Vera Treatment Algorithm

PV AT ASH 2025

Ep. 2: Integrating Rusfertide Into the Polycythemia Vera Treatment Algorithm

Talha Badar, MBBS, MD, Aaron Gerds, MD, Andrew Kuykendall, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Ep. 1: Clinical Insights: New Approaches to Hematocrit Control in Polycythemia Vera

PV AT ASH 2025

Ep. 1: Clinical Insights: New Approaches to Hematocrit Control in Polycythemia Vera

Talha Badar, MBBS, MD, Aaron Gerds, MD, Andrew Kuykendall, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

OncUpdates

Empowering oncology professionals with The latest insights, breakthroughs, And expert opinions

Quick Links

  • About Us
  • Upcoming Events
  • Follow on X
  • Follow on LinkedIn
  • Follow on YouTube

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Authors
  • Contact Us

Subscribe to Our Newsletters


Property of SignifyMD LLC, All Rights Reserved 2026 SignifyMD LLC PO Box 512, Brielle, NJ 08730


Oncology Resources | Hematology Support | Community Oncology